PNV 5032
Alternative Names: PNV-5032Latest Information Update: 13 Feb 2022
At a glance
- Originator Purnovate
- Developer ADial Pharmaceuticals; Purnovate
- Class Antiasthmatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Asthma